Trump White House media ban; Honor Health pancreatic cancer treatment; the science of sweating

On this episode of “Arizona Horizon,” Roy Herrera, Founding Partner at Herrera Arellano, discussed the return of the three news outlets that were banned from the White House in early September. The three news outlets have now asked for an immediate hearing to address the continued ban. 

We also heard from Dr. Erkut Borazanci, Medical Director of the Oncology Research Division at the HonorHealth Research Institute, who discussed Arizona’s role in the newly FDA-approved pancreatic cancer drug. The HonorHealth Research Institute had the opportunity to provide patients in Arizona with the drug Daraxonrasib through an extended access program.

Finally, Konrad Rykaczewski, Associate Professor of Engineering at ASU, joined us to discuss a new study on the science of sweating. The ASU research will help scientists recommend new safety guidelines for heat stress.